A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides

Glabellar Rhytides Clinical Trial

Official title:
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Forehead and Glabellar Facial Rhytides

Status Completed

Clinical Trial Summary

This is a safety and efficacy study of onabotulinumtoxinA in subjects with forehead and glabellar facial rhytides (frown lines).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02261467
Study type	Interventional
Source	Allergan
Contact
Status	Completed
Phase	Phase 3
Start date	October 21, 2014
Completion date	April 26, 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02261493` - A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides	Phase 3
Completed	`NCT00752050` - Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows	Phase 3
Completed	`NCT01814670` - Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines	Phase 4
Completed	`NCT00752297` - Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows	Phase 3
Completed	`NCT00752258` - A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows	Phase 3